This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
Alpha-synuclein Immunotherapy for Parkinson´s disease
Investments > €500k
Sweden
Parkinson’s disease & PD-related disorders
2016